This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Choroidal thickness in ocular sarcoidosis by OCT measurement

Choroidal thickness in ocular sarcoidosis by OCT measurement
Reviewed by Nikolaos D Georgakarakos

1 December 2014 | Nikolaos D Georgakarakos | EYE - Vitreo-Retinal

This is the first study to evaluate the choroidal thickness in patients with ocular sarcoidosis during the quiescent phase using enhanced depth imaging optical coherence tomography (EDI-OCT) and comparing with normal subjects. Ocular sarcoidosis may affect the choroidal circulation (occlusive arteriolitis) which may induce the reduction of the choroidal thickness. During the inflammatory phase the thickness of the choroid may change. The study included 18 eyes of nine patients with ocular sarcoidosis (eight women and one man mean age 59 years +/-18.5) and their subfoveal choroidal thickness was measured using EDI-OCT and compared to the age, sex and spherical equivalent-matched normal subjects. The mean subfoveal choroidal thickness was 281.76+/- 88µm in patients with sarcoidosis and 432+/-71µm in controls. Significant differences were found at points between the nasal 1500µm and temporal 1000µm to the fovea between patients and control group (p=0.002 at fovea). Therefore, the patients with sarcoidosis had thinner choroidal layer in the quiescent phase when compared to control subjects. 

Choroidal thickness in ocular sarcoidosis during quiescent phase using enhanced depth imaging optical coherence tomography.
Gungor SG, Akkoyum I, Reyhan NH, et al.
OCULAR IMMUNOLOGY AND IMFLAMMATION
2014;22(4):287-93.
Share This
CONTRIBUTOR
Nikolaos D Georgakarakos

Moorfields Eye Hospital, London, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency